Anders Engeland is a statistician and professor of epidemiology at Section for Epidemiology and Medical Statistics (EPISTAT) at the Department of Public Health and Primary Care (IGS), University of Bergen and senior researcher at the Norwegian Institute of Public Health (Norwegian Institute of Public Health - NIPH (fhi.no)). He has an extensive experience and broad competence within the fields of cancer, perinatal and pharmacoepidemiology, and has been involved in numerous international collaborations. Engeland has co-authored more than 200 scientific papers.

• Teacher at courses in Epidemiology for medical- and PhD-students
• Supervisor for medical- and PhD-students

2024

• Rolová, Gabriela; Engeland, Anders; Odsbu, Ingvild et al. (2024). Mortality among patients with long-term prescription opioid use in Norway. (external link)
• Hegvik, Tor-Arne; Zhou, Yanyan; Brauckhoff, Katrin et al. (2024). Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study. (external link)
• Sharifian, Mohammad Jalil; Igland, Jannicke; Klungsøyr, Kari et al. (2024). Incidence trends of adult glioma in Norway and its association with occupation and education: A registry-based cohort study. (external link)

2023

• Brikell, Margareta Isabell; Yao, Honghui; Li, Lin et al. (2023). ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases. (external link)
• Daltveit, Dagrun Slettebø; Klungsøyr, Kari; Engeland, Anders et al. (2023). Cancer risk in the siblings of individuals with major birth defects: a large Nordic population-based case-control study. (external link)
• Fritz, Josef; Jochems, Sylvia H. J.; Bjørge, Tone et al. (2023). Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts. (external link)
• Abril, Jazmine; Trabert, Britton; Troisi, Rebecca et al. (2023). Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case–control study. (external link)
• Bjørge, Tone; Hjellvik, Vidar; Bjørge, Line et al. (2023). Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study. (external link)
• Bröms, Gabriella; Hernandez-Diaz, Sonia; Huybrechts, Krista F. et al. (2023). Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study. (external link)
• Sun, Ming; Fritz, Josef; Häggström, Christel et al. (2023). Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study. (external link)
• Kjerpeseth, Lars Jøran; Cesta, Carolyn E.; Furu, Kari et al. (2023). Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study. (external link)
• Paramsothy, Abira; Hegvik, Tor-Arne; Engeland, Anders et al. (2023). Fetal Exposure to Preeclampsia and Later Risk of Cardiometabolic Disorders: A Population-Based Cohort Study. (external link)

2022

• Forster, Rachel Bedenis; Engeland, Anders; Kvåle, Rune et al. (2022). Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer. (external link)
• Daltveit, Dagrun Slettebø; Klungsøyr, Kari; Engeland, Anders et al. (2022). Sex differences in childhood cancer risk among children with major birth defects: a Nordic population-based nested case-control study. (external link)
• Engeland, Anders; Nystad, Wenche; Selmer, Randi Marie (2022). The Cancer Registry of Norway – “a ground for scientific harvesting”. (external link)
• Kitahara, Cari M.; Daltveit, Dagrun Slettebø; Ekbom, Anders et al. (2022). Maternal Health, Pregnancy and Offspring Factors, and Maternal Thyroid Cancer Risk: A Nordic Population-Based Registry Study. (external link)
• Daltveit , Dagrun Slettebø; Bjørge, Tone; Klungsøyr, Kari et al. (2022). Childhood cancer risk among children with major birth defects – sex differences?. (external link)
• Daltveit , Dagrun Slettebø; Klungsøyr, Kari; Engeland, Anders et al. (2022). Cancer risk in individuals with siblings with major birth defects: A large Nordic population-based case-control study. (external link)
• Cohen, Jacqueline Mallory; Alvestad, Silje; Cesta, Carolyn E. et al. (2022). Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations. (external link)
• Hegvik, Tor-Arne; Klungsøyr, Kari; Kuja-Halkola, Ralf et al. (2022). Labor epidural analgesia and subsequent risk of offspring autism spectrum disorder and attention-deficit/hyperactivity disorder: a cross-national cohort study of 4.5 million individuals and their siblings. (external link)
• Sun, Ming; Bjørge, Tone; Teleka, Stanley et al. (2022). Interaction of leisure-time physical activity with body mass index on the risk of obesity-related cancers: A pooled study. (external link)

2021

• Daltveit , Dagrun Slettebø; Klungsøyr, Kari; Engeland, Anders et al. (2021). Childhood cancer risk among individuals with major birth defects: A Nordic collaborative study. (external link)
• Cesta, Carolyn E.; Segovia Chacón, Silvia; Engeland, Anders et al. (2021). Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia. (external link)
• Wood, Angela M.; Jonsson, Håkan; Nagel, Gabriele et al. (2021). The Inverse Association of Body Mass Index with Lung Cancer: Exploring Residual Confounding, Metabolic Aberrations and Within-Person Variability in Smoking. (external link)
• Engeland, Anders; Ghaderi, Sara; dos-Santos-Silva, Isabel et al. (2021). Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population-based cohort study. (external link)
• Lupattelli, Angela; Karlstad, Øystein; Engeland, Anders et al. (2021). The Norwegian Society for Pharmacoepidemiology. (external link)
• Posserud, Maj-Britt Rocio; Solberg, Berit Skretting; Engeland, Anders et al. (2021). Male to female ratios in autism spectrum disorders by age, intellectual disability and attention-deficit/hyperactivity disorder. (external link)
• Nagel, Gabriele; Bjørge, Tone; Jaensch, Andrea et al. (2021). Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project. (external link)

2020

• Daltveit , Dagrun Slettebø; Klungsøyr, Kari; Engeland, Anders et al. (2020). Cancer risk in individuals with major birth defects: A large Nordic population-based case-control study among children, adolescents, and adults. (external link)
• Felde, Gunhild; Engeland, Anders; Hunskaar, Steinar (2020). Urinary incontinence associated with anxiety and depression: the impact of psychotropic drugs in a cross-sectional study from the Norwegian HUNT study. (external link)
• Cesta, Carolyn; Engeland, Anders; Karlsson, Pär et al. (2020). Incidence of Malformations After Early Pregnancy Exposure to Modafinil in Sweden and Norway. (external link)
• Sköld, Camilla; Bjørge, Tone; Ekbom, Anders et al. (2020). Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study. (external link)
• Kitahara, Cari M; Slettebø, Dagrun Daltveit; Ekbom, Anders et al. (2020). Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study. (external link)
• Reigstad, Marte Myhre; Storeng, Eleftheria (Ritsa) T.; Furu, Kari et al. (2020). Validation of assisted reproductive technology in the Medical Birth Registry of Norway versus the Norwegian Prescription Database. (external link)
• Solberg, Berit Skretting; Hegvik, Tor-Arne; Halmøy, Anne et al. (2020). Sex differences in parent–offspring recurrence of attention-deficit/hyperactivity disorder. (external link)
• Daltveit , Dagrun Slettebø; Klungsøyr, Kari; Engeland, Anders et al. (2020). Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults. (external link)
• Reutfors, Johan; Cesta, Carolyn; Cohen, Jacqueline Mallory et al. (2020). Antipsychotic drug use in pregnancy: A multinational study from ten countries. (external link)
• Daltveit , Dagrun Slettebø; Engeland, Anders; Klungsøyr, Kari et al. (2020). Medfødte misdannelser gir økt risiko for kreft. (external link)

2019

• Fritz, Josef; Bjørge, Tone; Nagel, Gabriele et al. (2019). The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. (external link)
• Häggström, Christel; Jonsson, Håkan; Bjørge, Tone et al. (2019). Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals. (external link)
• Solberg, Berit Skretting; Zayats, Tetyana; Posserud, Maj-Britt Rocio et al. (2019). Patterns of psychiatric comorbidity and genetic correlations provide new insights into differences between attention-deficit/hyperactivity disorder and autism spectrum disorder. (external link)
• Handal, Marte; Nechanská, Blanka; Skurtveit, Svetlana et al. (2019). Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway. (external link)
• Solberg, Berit Skretting; Hegvik, Tor-Arne; Halmøy, Anne et al. (2019). Parent-offspring recurrence of attention-deficit/hyperactivity disorder. (external link)
• Trabert, Britton; Troisi, Rebecca; Grotmol, Tom et al. (2019). Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study. (external link)
• Solberg, Berit Skretting; Hegvik, Tor-Arne; Zayats, Tetyana et al. (2019). Parent-offspring recurrence of ADHD. (external link)
• Børsheim, Anna Wie; Engeland, Anders; Gilhus, Nils Erik (2019). Epilepsy and autoimmune diseases: Comorbidity in a national patient cohort. (external link)
• Bjørge, Tone; Häggström, Christel; Ghaderi, Sara et al. (2019). BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study. (external link)

2018

• Sköld, Camilla; Bjørge, Tone; Ekbom, Anders et al. (2018). Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. (external link)
• Troisi, Rebecca; Ording, Anne Gulbech; Grotmol, Tom et al. (2018). Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study. (external link)
• Nechanská, Blanka; Mravčík, Viktor; Skurtveit, Svetlana et al. (2018). Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. (external link)
• Bateman, Brian T.; Heide-Jørgensen, Uffe; Einarsdottir, Kristjana et al. (2018). Beta-blocker use in pregnancy and the risk of congenital malformations: An international cohort study. (external link)
• Antonazzo, Ippazio Cosimo; Riise, Trond; Cortese, Marianna et al. (2018). Diabetes is associated with decreased migraine risk: A nationwide cohort study. (external link)
• Solberg, Berit Skretting; Zayats, Tetyana; Posserud, Maj-Britt Rocio et al. (2018). Psychiatric comorbidities in adults with ADHD and/or autism: Can patterns of comorbidities together with genetics add knowledge on etiologic relations? . (external link)
• Solberg, Berit Skretting; Zayats, Tetyana; Posserud, Maj-Britt Rocio et al. (2018). Psychiatric comorbidity and genetic correlations provide new insights into differences between ADHD and autism . (external link)
• Solberg, Berit Skretting; Zayats, Tetyana; Posserud, Maj-Britt Rocio et al. (2018). Psychiatric comorbidity and genetic correlations provide new insights into differences between ADHD and autism . (external link)
• Pasternak, Björn; Wintzell, Viktor; Furu, Kari et al. (2018). Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death. (external link)
• Engeland, Anders; Bjørge, Tone; Klungsøyr, Kari et al. (2018). Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. (external link)
• Cortese, Marianna; Riise, Trond; Engeland, Anders et al. (2018). Urate and the risk of Parkinson's disease in men and women. (external link)

2017

• Hegvik, Tor-Arne; Instanes, Johanne Telnes; Haavik, Jan et al. (2017). Correction to: Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. (external link)
• Mittal, Shuchi; Bjørnevik, Kjetil Lauvland; Im, Doo Soon et al. (2017). beta(2)-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson's disease. (external link)
• Nechanska, Blanka; Mravcik, Viktor; Skurtveit, Svetlana et al. (2017). Condition of newborns of women received OMT and opiates during pregnancy: comparison of Czech and Norwegian cohorts. (external link)
• Handal, Marte; Nechanska, Blanka; Lund, Ingunn Olea et al. (2017). OMT or drug abuse during pregnancy - does it affect the offspring? Results from Nationwide registry studies in the Czech Republic and Norway. (external link)
• Hegvik, Tor-Arne; Instanes, Johanne Telnes; Haavik, Jan et al. (2017). Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. (external link)
• Engeland, Anders; Bjørge, Tone; Klungsøyr, Kari et al. (2017). Preterm births and use of medication in early adulthood: a population-based registry study. (external link)
• Solberg, Berit Skretting; Halmøy, Anne; Engeland, Anders et al. (2017). Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. (external link)
• Huybrechts, Krista F; Bröms, Gabriella; Christensen, Lotte Brix et al. (2017). Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: A cohort study from the international pregnancy safety study consortium. (external link)
• Charlton, R A; Bettoli, V; Bos, H J et al. (2017). The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. (external link)
• Graner, Sophie; Svensson, Tobias; Beau, Anna-Belle et al. (2017). Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. (external link)
• Handal, Marte; Nechanská, Blanka; Mravčík, Viktor et al. (2017). Neonatal Outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. (external link)
• Solberg, Berit Skretting; Halmøy, Anne; Engeland, Anders et al. (2017). Psychiatric comorbidities in male and female adults with ADHD. (external link)
• Solberg, Berit Skretting; Halmøy, Anne; Engeland, Anders et al. (2017). Gender Differences in Psychiatric Comorbidity: A Population-based Study of 40,000 Adults with Attention-Deficit/Hyperactivity Disorder. (external link)
• Vik, Kirsti Lund; Gislefoss, Randi Elin; Tretli, Steinar et al. (2017). Cohort Profile Update: The Janus Serum Bank Cohort in Norway. (external link)
• Instanes, Johanne Telnes; Halmøy, Anne; Engeland, Anders et al. (2017). Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. (external link)

2016

• Bjørge, Tone; Gissler, Mika; Ording, Anne Gulbech et al. (2016). Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study. (external link)
• Jordan, Sue; Morris, Joan K; Davies, Gareth I. et al. (2016). Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: Analysis of linked databases in Wales, Norway and Funen, Denmark. (external link)
• Bakken, Marit Stordal; Engeland, Anders; Engesæter, Lars B. et al. (2016). Psychotropic Drug Exposure and Hip Fractures. (external link)
• Magnus, Maria Christine; Håberg, Siri Eldevik; Magnus, Per et al. (2016). Pre-eclampsia and childhood asthma. (external link)
• Garne, Ester; Vinkel Hansen, Anne; Morris, Joan K. et al. (2016). Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study. (external link)
• Charlton, Rachel A; Klungsøyr, Kari; Neville, Amanda J. et al. (2016). Prescribing of antidiabetic medicines before, during and after pregnancy: A study in seven European regions. (external link)
• Charlton, Rachel A; Pierini, Anna; Klungsøyr, Kari et al. (2016). Asthma medication prescribing before, during and after pregnancy: a study in seven European regions. (external link)
• Ghaderi, Sara; Engeland, Anders; Gunnes, Maria Winther et al. (2016). Educational attainment among long-term survivors of cancer in childhood and adolescence: a Norwegian population-based cohort study. (external link)
• Bakken, Marit Stordal; Schjøtt, Jan; Engeland, Anders et al. (2016). Antipsychotic drugs and risk of hip fracture among people older than 60 years in Norway. (external link)
• Knudsen-Baas, Kristin Marie; Engeland, Anders; Gilhus, Nils Erik et al. (2016). Does the choice of antiepileptic drug affect survival in glioblastoma patients?. (external link)

2015

• Kieler, H; Malm, H; Artama, M et al. (2015). Use of antidepressants and association with elective termination of pregnancy: population based case-control study. (external link)
• Charlton, Rachel ; Garne, Ester; Wang, Hao et al. (2015). Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions. (external link)
• Stocks, Tanja; Bjørge, Tone; Ulmer, Hanno et al. (2015). Metabolic risk score and cancer risk: pooled analysis of seven cohorts. (external link)
• Ruths, Sabine; Bakken, Marit Stordal; Ranhoff, Anette Hylen et al. (2015). Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study. (external link)
• Engeland, Anders; Bjørge, Tone; Klungsøyr, Kari et al. (2015). Preeclampsia in pregnancy and later use of antihypertensive drugs. (external link)
• Bjerkaas, Eivind; Parajuli, Ranjan; Engeland, Anders et al. (2015). Social inequalities and smoking-associated breast cancer - Results from a prospective cohort study. (external link)
• Furu, Kari; Kieler, Helle; Haglund, Bengt et al. (2015). Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: Population based cohort study and sibling design. (external link)

2014

• Bakken, Marit Stordal; Engeland, Anders; Engesæter, Lars B. et al. (2014). Associations between hip fractures & psychotropic drugs - a Nationwide prospective cohort study. (external link)
• Bakken, Marit Stordal; Engeland, Anders; Engesæter, Lars B. et al. (2014). Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a 6-year follow-up study based on nationwide registries. (external link)
• Bjerkaas, Eivind; Parajuli, Ranjan; Engeland, Anders et al. (2014). The Association between Lifetime Smoking Exposure and Breast Cancer Mortality – Results from a Norwegian Cohort. (external link)
• Løkeland, Mette; Iversen, Ole-Erik; Engeland, Anders et al. (2014). Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation. (external link)
• Bakken, Marit Stordal; Engeland, Anders; Engesæter, Lars B. et al. (2014). Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. (external link)
• Borena, Wegene; Edlinger, Michael; Bjørge, Tone et al. (2014). A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. (external link)
• Andersen, Jintana Bunpan; Heldal, Anne Taraldsen; Engeland, Anders et al. (2014). Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. (external link)
• Wirén, Sara; Häggstrøm, Christel; Ulmer, Hanno et al. (2014). Pooled cohort study on height and risk of cancer and cancer death. (external link)
• Andersen, Jintana Bunpan; Owe, Jone Furulund; Engeland, Anders et al. (2014). Total drug treatment and comorbidity in myasthenia gravis: A population-based cohort study. (external link)
• Riska, Solvor; Skurtveit, Svetlana; Furu, Kari et al. (2014). Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. (external link)
• Lindkvist, Björn; Johansen, Dorthe; Stocks, Tanja et al. (2014). Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: A prospective study of 580 000 subjects within the Me-Can project. (external link)
• Häggström, Christel; Stocks, Tanja; Nagel, Gabriele et al. (2014). Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations. (external link)

2013

• Lund, Ingunn Olea; Skurtveit, Svetlana; Engeland, Anders et al. (2013). Prescription drug use among pregnant women in opioid Maintenance Treatment. (external link)
• Bakken, Marit Stordal; Engeland, Anders; Engesæter, Lars B. et al. (2013). Hip fracture and use of antidepressant drugs. (external link)
• Stephansson, Olof; Kieler, Helle; Haglund, Bengt et al. (2013). Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. (external link)
• Wiren, Sara; Häggström, Christel; Ulmer, Hanno et al. (2013). Pooled cohort study on height and risk of cancer and cancer death. (external link)
• Bjørge, Tone; Sørensen, Henrik Toft; Grotmol, Tom et al. (2013). Fetal growth and childhood cancer: A population-based study. (external link)
• Häggström, Christel; Rapp, Kilian; Stocks, Tanja et al. (2013). Metabolic Factors Associated with Risk of Renal Cell Carcinoma. (external link)
• Bakken, Marit Stordal; Engeland, Anders; Engesæter, Lars B. et al. (2013). Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry. (external link)
• Ghaderi, Sara; Engeland, Anders; Moster, Dag et al. (2013). Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: a Norwegian population-based cohort study. (external link)
• Strohmaier, S; Edlinger, M; Manjer, J et al. (2013). Total serum cholesterol and cancer incidence in the Metabolic Syndrome and Cancer Project (Me-Can). (external link)
• Håberg, Siri Eldevik; Trogstad, Lill; Gunnes, Nina et al. (2013). Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination. (external link)
• Engeland, Anders; Bjørge, Tone; Daltveit, Anne Kjersti et al. (2013). Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340,000 pregnancies using Norwegian population-based databases. (external link)
• Lindkvist, Björn; Almquist, Martin; Bjørge, Tone et al. (2013). Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic syndrome and Cancer project (Me-Can). (external link)
• Bjerkaas, Eivind; Parajuli, Ranjan; Weiderpass, Elisabete et al. (2013). Smoking duration before first childbirth: an emerging risk factor for breast cancer? Results from 302,865 Norwegian women. (external link)
• Håberg, Siri Eldevik; Trogstad, Lill; Gunnes, Nina et al. (2013). Risk of Fetal Death After Pandemic Influenza Virus Infection or Vaccination EDITORIAL COMMENT. (external link)

2012

• Borena, Wegene; Strohmaier, Susanne; Lukanova, Annekatrin et al. (2012). Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. (external link)
• Edlinger, Michael; Strohmaier, Susanne; Jonsson, Håkan et al. (2012). Blood pressure and other metabolic syndrome factors and risk of brain tumor in the large population-based Me-Can cohort study. (external link)
• Nagel, Gabriele; Bjørge, Tone; Manjer, Jonas et al. (2012). Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). (external link)
• Nagel, Gabriele; Stocks, Tanja; Späth, Daniela et al. (2012). Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). (external link)
• Bramness, Jørgen Gustav; Skurtveit, Svetlana; Mørland, Jørg et al. (2012). An increased risk of motor vehicle accidents after prescription of methadone. (external link)
• Bramness, Jørgen Gustav; Furu, Kari; Skurtveit, Svetlana et al. (2012). Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential. (external link)
• Kieler, Helle; Artama, Miia; Engeland, Anders et al. (2012). Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. (external link)
• Ulmer, Hanno; Bjørge, Tone; Concin, Hans et al. (2012). Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). (external link)
• Viktil, Kirsten Kilvik; Engeland, Anders; Furu, Kari (2012). Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers. (external link)
• Stocks, Tanja; Van Hemelrijck, Mieke; Manjer, Jonas et al. (2012). Blood pressure and risk of cancer incidence and mortality in the Metabolic syndrome and cancer project. (external link)
• Bakken, Marit Stordal; Ranhoff, Anette Hylen; Engeland, Anders et al. (2012). Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards. (external link)
• Halvorsen, Kjell Hermann; Granås, Anne Gerd; Engeland, Anders et al. (2012). Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs. (external link)
• Bakken, Marit Stordal; Engeland, Anders; Engesæter, Lars B. et al. (2012). Increased hip fracture risk in older persons exposed to antidepressant drugs. (external link)
• Bakken, Marit Stordal; Engeland, Anders; Engesæter, Lars B. et al. (2012). Increased hip fracture risk in older persons exposed to antidepressant drugs. (external link)
• Häggström, Christel; Stocks, Tanja; Ulmert, David et al. (2012). Prospective study on metabolic factors and risk of prostate cancer. (external link)
• Svendal, Gjertrud Øvreås; Fasmer, Ole Bernt; Engeland, Anders et al. (2012). Co-prescription of medication for bipolar disorder and diabetes mellitus: A nationwide population-based study. (external link)
• Håberg, Siri Eldevik; Trogstad, Lill; Gunnes, Nina et al. (2012). The 2009 Influenza Pandemic, Vaccination during Pregnancy and Fetal Death: A National Registry-Based Study in Norway. (external link)
• Lund, Ingunn Olea; Engeland, Anders; Furu, Kari et al. (2012). Prescription Drug Use among Pregnant Women in Opioid Maintenance Treatment. (external link)

2011

• Engeland, Anders; Bjørge, Tone; Daltveit, Anne Kjersti et al. (2011). Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. (external link)
• Stocks, Tanja; Lukanova, Annekatrin; Bjørge, Tone et al. (2011). Metabolic Factors and the Risk of Colorectal Cancer in 580,000 Men and Women in the Metabolic Syndrome and Cancer Project (Me-Can). (external link)
• Espnes, Marte Gravseth; Bjørge, Tone; Engeland, Anders (2011). Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. (external link)
• Almquist, Martin; Johansen, Dorthe; Bjørge, Tone et al. (2011). Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). (external link)
• Borena, Wegene; Stocks, Tanja; Jonsson, Håkan et al. (2011). Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. (external link)
• Häggström, Christel; Stocks, Tanja; Rapp, Kilian et al. (2011). Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). (external link)
• Bramness, Jørgen Gustav; Skurtveit, Svetlana; Mørland, Jørg et al. (2011). An increased risk of road traffic accidents after prescriptions of methadone. (external link)
• Lund, Ingunn Olea; Handal, Marte; Engeland, Anders et al. (2011). USE OF PRESCRIBED DRUGS FOR THE NERVOUS SYSTEM AMONG WOMEN IN OPIOID MAINTENANCE TREATMENT BEFORE AND DURING PREGNANCY IN NORWAY, 2004-2008. (external link)
• Handal, Marte; Engeland, Anders; Rønning, Marit et al. (2011). Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. (external link)
• Bjørge, Tone; Lukanova, Annekatrin; Tretli, Steinar et al. (2011). Metabolic risk factors and ovarian cancer in the Metabolic syndrome and cancer project. (external link)
• Handal, Marte; Skurtveit, Svetlana; Furu, Kari et al. (2011). Use of Legally Prescribed Opioid Analgesics in Pregnant Women and Risk of Spontaneous Preterm Birth. A Population Based Cohort Study, Norway 2004-2008. (external link)
• Nagel, Gabriele; Concin, Hans; Bjørge, Tone et al. (2011). Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). (external link)
• Halvorsen, Kjell H.; Granås, Anne Gerd; Engeland, Anders et al. (2011). Prescribing quality for older people in nursing homes and home care services using multi-dose dispensed drugs. (external link)

2010

• Bramness, Jørgen Gustav; Sandvik, Pål; Engeland, Anders et al. (2010). Does Pregabalin (Lyrica (R)) help patients reduce their use of Benzodiazepines? A comparison with gabapentin using the norwegian prescription database. (external link)
• Stocks, Tanja; Borena, Wegene; Wegene, Borena et al. (2010). Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). (external link)
• Bjørge, Tone; Lukanova, Annekatrin; Jonsson, Håkan et al. (2010). Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. (external link)
• Andersen, JA; Engeland, Anders; Owe, Jone Furulund et al. (2010). Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. (external link)
• Bjørge, Tone; Stocks, Tanja; Lukanova, Annekatrin et al. (2010). Metabolic syndrome and endometrial carcinoma. (external link)
• Johansen, Dorthe; Stocks, Tanja; Jonsson, Håkan et al. (2010). Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. (external link)

2009

• Handal, Marte; Engeland, Anders; Skurtveit, Svetlana et al. (2009). Use of opioids in mothers and fathers before and during pregnancy-2004-2006. (external link)
• Andersen, JB; Owe, JF; Engeland, Anders et al. (2009). Myasthenia gravis requiring drug treatment in a national population cohort. (external link)
• Bjørge, Tone; Cnattingius, Sven; Engeland, Anders et al. (2009). Fetal down syndrome and the risk of maternal breast cancer. (external link)
• Engeland, Anders; Bjørge, Tone; Daltveit, Anne Kjersti Nesje et al. (2009). Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. (external link)
• Skurtveit, Svetlana ; Strøm, Hanne; Skrivarhaug, T et al. (2009). Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study. (external link)
• Viktil, Kirsten K; Engeland, Anders; Furu, Kari (2009). Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study. (external link)
• Bramness, Jørgen G.; Grøholt, Berit; Engeland, Anders et al. (2009). The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007-A prescription database study. (external link)
• Hausken, Anne M; Furu, Kari; Skurtveit, Svetlana et al. (2009). Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. (external link)
• Bachs, Liliana Casulleras; Engeland, Anders; Mørland, Jørg et al. (2009). The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. (external link)
• Bramness, Jørgen; Skurtveit, Svetlana; Neutel, Ineke et al. (2009). An increased risk of road traffic accidents after prescriptions of lithium or valproate?. (external link)

2008

• Furu, Kari; Engeland, Anders; Viktil, Kirsten K (2008). Use of antirheumatic drugs in mothers and fathers before and during pregnancy, 2004-2006. (external link)
• Bramness, Jørgen G.; Grøholt, Berit; Engeland, Anders et al. (2008). The use of lithium, valproate or lamotrigine as mood stabilizers in children and adolescents in Norway 2004-2007. (external link)
• Viktil, Kirsten Kilvik; Engeland, A; Furu, Kari (2008). Use of antirheumatic drugs in mothers and fathers before and during pregnancy. (external link)
• Skurtveit, Svetlana ; Strøm, Hanne; Skrivarhaug, Torild et al. (2008). Patients treated with insulin or oral blood glucose lowering drugs and risk of road traffic accidents: A registry-based cohort study. (external link)
• Bramness, Jørgen G.; Skurtveit, Svetlana ; Neutel, Ineke et al. (2008). No increase in risk of road traffic accidents after prescriptions of mood stabilizers. (external link)
• Bramness, Jørgen G.; Skurtveit, Svetlana ; Neutel, C Ineke et al. (2008). Minor increase in risk of road traffic accidents after prescriptions of antidepressants: A study of population registry data in Norway. (external link)
• Bjørge, Tone; Cnattingius, Sven; Lie, Rolv Terje et al. (2008). Cancer risk in children with birth defects and in their families: A population based cohort study of 5.2 million children from Norway and Sweden. (external link)
• Gustavsen, Ingebjørg; Bramness, Jørgen G.; Skurtveit, Svetlana et al. (2008). Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. (external link)
• Anderssen, Sigmund A.; Engeland, Anders; Søgaard, Anne-Johanne et al. (2008). Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. (external link)
• Engeland, Anders; Bramness, Jørgen; Daltveit, Anne Kjersti et al. (2008). Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006. (external link)
• Bachs, Liliana Casulleras; Bramness, Jørgen G.; Engeland, Anders et al. (2008). Repeated dispensing of codeine is associated with high consumption of benzodiazepines. (external link)
• Bjørge, Tone; Engeland, Anders; Tretli, S et al. (2008). Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study. (external link)
• Engeland, Anders; Bramness, Jørgen G.; Mørland, Jørg et al. (2008). Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie. (external link)
• Næss, Øyvind; Søgaard, Anne Johanne; Arnesen, Egil et al. (2008). Cohort Profile: Cohort of Norway (CONOR). (external link)
• Bjørge, Tone; Engeland, Anders; Tverdal, Aage et al. (2008). Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230,000 Norwegian adolescents. (external link)

2007

• Karlstad, Øystein; Furu, Kari; Engeland, Anders (2007). Use of stimulants for ADHD among children and adolescents in Norway: - a population based study 2004-2006. (external link)
• Engeland, Anders; Bramness, Jørgen G.; Daltveit, Anne Kjersti Nesje et al. (2007). Prescription drug use before, during and after pregnancy among 50,000 women in Norway in 2004-2005. (external link)
• Skurtveit, Svetlana ; Mørland, Jørg; Bramness, Jørgen G. et al. (2007). Traffic accident risks associated with the prescription of medicinal drugs: A registry-based cohort study. (external link)
• Furu, Kari; Karlstad, O; Engeland, Anders (2007). Psychostimulant use among children and adolescents with ADHD in Norway: A population based study 2004-2006. (external link)
• Bramness, Jørgen Gustav; Skurtveit, Svetlana ; Mørland, Jørg et al. (2007). The risk of traffic accidents after prescriptions of carisoprodol. (external link)
• Engeland, Anders; Skurtveit, Svetlana ; Mørland, Jørg (2007). Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study. (external link)
• Bjørge, Tone; Engeland, Anders; Tretli, Steinar et al. (2007). Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. (external link)
• Bramness, Jørgen Gustav; Furu, Kari; Engeland, Anders et al. (2007). Carisoprodol use and abuse in Norway. A pharmacoepidemiological study. (external link)
• Blix, Hege Salvesen; Engeland, Anders; Litleskare, Irene et al. (2007). Age- and gender-specific antibacterial prescribing in Norway. (external link)
• Engeland, Anders; Bramness, Jørgen G.; Daltveit, Anne Kjersti Nesje et al. (2007). Prescription drug use before, during and after pregnancy among 50 000 women in Norway in 2004-2005. (external link)
• Engeland, Anders (2007). Medikamentbruk i forbindelse med svangerskap. (external link)
• Engeland, Anders (2007). Medikamentbruk i forbindelse med svangerskap. (external link)
• Engeland, Anders; Bramness, Jørgen G; Daltveit, Anne Kjersti et al. (2007). Prescription drug use before, during and after pregnancy among 50 000 women in Norway in 2004-2005. (external link)
• Gustavsen, Ingebjørg; Bramness, Jørgen G.; Skurtveit, Svetlana et al. (2007). Traffic accident risk associated with the prescription of hypnotic drugs: a registry-based cohort study. (external link)
• Skurtveit, Svetlana ; Engeland, Anders; Bramness, Jørgen G. et al. (2007). Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie. (external link)
• Furu, Kari; Karlstad, Øystein; Engeland, Anders (2007). Psychostimulant use among children and adolescents with ADHD in Norway: a population based study 2004-2006. (external link)
• Hartz, Ingeborg; Sakshaug, Solveig; Furu, Kari et al. (2007). Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study. (external link)
• Engeland, Anders; Tretli, Steinar; Hansen, Svein et al. (2007). Height and body mass index and risk of lymphohematopoietic malignancies in two million norwegian men and women. (external link)
• Bramness, Jørgen G.; Engeland, Anders; Furu, Kari (2007). Antidepressiver hos barn og ungdom - førte advarsler til færre forskrivninger?. (external link)

2006

• Hartz, Ingeborg; Solveig, Sakshaug; Sakshaug, Solveig et al. (2006). Comparison of statin use in three Norwegian counties in 2004 - An individualised prescription database study. (external link)
• Litleskare, Irene; Blix, Hege Salvesen; Engeland, Anders et al. (2006). Age and sex specific antibacterial prescribing in Norway. (external link)
• Strøm, Hanne; Engeland, Anders; Eriksen, Elisabeth et al. (2006). How many and who are receiving medication for treatment of diabetes mellitus in Norway?. (external link)
• Bramness, Jørgen G.; Furu, Kari; Engeland, Anders et al. (2006). The pharmacoepidemiology of Carisoprodol misuse and abuse. (external link)
• Bramness, Jørgen G.; Engeland, Anders; Furu, Kari (2006). The impact of medicinal authority's warnings on the prescribing of SSRI antidepressants to children and adolescents in Norway. (external link)
• Bjørge, Tone; Tretli, Steinar; Lie, Agnes kathrine et al. (2006). The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. (external link)
• Engeland, Anders; Tretli, Steinar; Akslen, Lars Andreas et al. (2006). Body size and thyroid cancer in two million Norwegian men and women. (external link)
• Bramness, Jørgen Gustav; Skurtveit, Svetlana ; Furu, Kari et al. (2006). Endringer i salg og bruk av flunitrazepam etter 1999. (external link)
• Strøm, Hanne; Engeland, Anders; Eriksen, Elisabeth et al. (2006). Hvor mange og hvem behandles medikamentelt for diabetes mellitus?. (external link)
• Flugsrud, Gunnar B.; Nordsletten, Lars; Espehaug, Birgitte et al. (2006). The impact of body mass index on later total hip arthroplasty for primary osteoarthritis - A cohort study in 1.2 million persons. (external link)
• Bramness, Jørgen G.; Engeland, Anders; Dalgard, Odd Steffen (2006). The prevalence and incidence of drug treated bipolar disorder in the adult(20-65 years) as seen in the Norwegian prescription database. (external link)
• Bramness, Jørgen G.; Engeland, Anders; Dalgard, Odd Steffen (2006). The prevalence and incidence of drug treated bipolar disorder in the adult(20-65 years) as seen in the Norwegian prescription database. (external link)
• Bramness, Jørgen G.; Furu, Kari; Engeland, Anders et al. (2006). The pharmacoepidemiology of carisoprodol misuse and abuse. (external link)
• Hartz, Ingeborg; Sakshaug, Solveig; Furu, Kari et al. (2006). Comparison of statin use in three Norwegian counties in 2004- an individualised prescription database study. (external link)
• Bramness, Jørgen G.; Engeland, Anders; Furu, Kari (2006). The Impact of Medicinal Authority's Warnings on the Prescribing of SSRI Antidepressants to Children and Adolescents in Norway. (external link)
• Strøm, Hanne; Engeland, Anders; Eriksen, Elisabeth et al. (2006). How many and who are receiving medication for treatment of diabetes mellitus in Norway?. (external link)

2005

• Bjørge, Tone; Tretli, Steinar; Engeland, Anders (2005). Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. (external link)
• Bjørge, Tone; Tretli, Steinar; Engeland, Anders (2005). Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. (external link)
• Furu, Kari; Strøm, Hanne; Rønning, Marit et al. (2005). The Norwegian prescription database(NorPD)-a new register for pharmacoepidemiologic research covering a whole nation. (external link)
• Hartz, Ingeborg; Eggen, Anne Elise; Njølstad, Inger et al. (2005). Do variations in sales of lipid-lowering drugs reflect true prevalences of use?A prescription database study of lipid-lowering drugs in regions with high (Hedmark), average (Oppland) and low (Troms) total sales. (external link)
• Engeland, Anders; Tretli, Steinar; Austad, G et al. (2005). Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. (external link)

2004

• Nystad, Wenche; Meyer, Haakon E; Nafstad, Per et al. (2004). Body mass index in relation to adult asthma among 135,000 Norwegian men and women. (external link)
• Engeland, Anders; Bjørge, Tone; Tverdal, A. et al. (2004). Obesity in adolescence and adulthood and the risk of adult mortality. (external link)
• Bjørge, Tone; Tretli, Steinar; Engeland, Anders (2004). Relation of Height and Body Mass Index to Renal Cell Carcinoma in Two Million Norwegian Men and Women. (external link)

2003

• Engeland, Anders; Søgaard, Anne Johanne (2003). CONOR (Cohort NORway) - en oversikt over en unik forskningdata. (external link)
• Engeland, Anders; Tretli, Steinar; Bjørge, T. (2003). Height, body mass index and prostate cancer: a follow-up of 950 000 Norwegian men. (external link)
• Engeland, Anders; Tretli, Steinar; Bjørge, T. (2003). Height, body mass index and ovarian cancer: a follow-up of 1.1 million Norwegian women. (external link)
• Engeland, Anders; Børge, Tone; Selmer, Randi Marie et al. (2003). A height and body mass index in relation to total mortality. (external link)
• Engeland, Anders; Børge, Tone; Søgaard, Anne Johanne et al. (2003). Body mass index in adolescence in relation to total mortality: 32 year follow-up 227, Norwegian and girls. (external link)
• Gustad, Torleif K; Meyer, Haakon E; Bjertness, Espen et al. (2003). Er det forskjeller i forekomst av underarmsbrudd mellom by og land i Norge? Data fra CONOR. (external link)

2002

• Bjørge, T.; Engeland, Anders; Luostarinen, Tapio et al. (2002). Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. (external link)
• Bjørge, T.; Engeland, Anders (2002). Bruk av p-piller og risiko for kreft. (external link)
• Engeland, Anders; Røysamb, Espen; Smedslund, Geir et al. (2002). Effects of first aid training in junior high schools. (external link)

2001

• Glattre, Eystein; Engeland, Anders; Jellum, Egil et al. (2001). Serum-albumin and risk of thyroid cancer: A population-based, matched case-control study. (external link)

2000

• Kopjar, Branko; Engeland, Anders; Bjørndal, Arild (2000). Impact of Safe Community program in Harstad on incidence of injuries. (external link)
• Myklestad, Ingri; Engeland, Anders (2000). Hjemmeulykker blant småbarn og potensialet for forebygging. (external link)

1999

• Berg, Jens Petter; Engeland, Anders; Jellum, Egil et al. (1999). Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: A matched case control study. (external link)
• Bjørge, T.; Trope, Claes Gøran; Engeland, Anders (1999). Screening mot kreft. (external link)

1998

• Bjørge, T.; Engeland, Anders; Hansen, S.W. et al. (1998). Prognosis of patients with Ovarian Cancer and Borderline Tumours Diagnosed in Norway between 1954 and 1993. (external link)
• Bjørge, T.; Engeland, Anders; Hansen, S.W. et al. (1998). Ovarialcancer og borderlinetumorer. (external link)
• Bjørge, T.; Engeland, Anders; Hansen, S.W. et al. (1998). Ovarialcancer og borderlinetumorer. (external link)
• Bjørge, T.; Engeland, Anders; Sundfør, Kolbein et al. (1998). Prognosis of 2.800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. (external link)

1997

• Bjørge, T.; Hakulinen, Timo; Engeland, Anders et al. (1997). A Prospective, Seroepidemiological Study of the Role of Human Papillomavirus in Esophageal Cancer in Norway. (external link)
• Bjørge, T.; Engeland, Anders; Hansen, S.W. et al. (1997). Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-93. (external link)
• Bjørge, T.; Engeland, Anders; Hansen, Svein et al. (1997). Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. (external link)
• Bjørge, T.; Engeland, Anders; Trope, Claes Gøran (1997). Ovarian Cancer-Are we making progress?. (external link)
• Trope, Claes Gøran; Bjørge, T.; Engeland, Anders et al. (1997). Prognosis of 3,000 Patients with Epithelial Ovarian Cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. (external link)
• Daae, L. N. W.; Engeland, Anders; Freng, Atle (1997). Serumproteiner hos pasienter med nyoppdaget kreft i munnhule/svelg. Hvilken lærdom gav konsentrasjonsmåling og elektroforese?. (external link)
• Hafstad, Anne; Aarø, Leif Edvard; Andersen, Aage et al. (1997). Provocative appe4als in anti-smoking a mass media campaigns targeting adolescents - the accumulated effect of multiple exposure. (external link)
• Bjørge, T.; Dillner, Joakim; Anttila, Tarja et al. (1997). Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. (external link)
• Engeland, Anders (1997). Smoking-associated cancers in Norway. (external link)

See a complete overview of publications in Cristin.

List of publications in peer-reviewed journals

1. Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, Magnus K, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic cancer registries. APMIS Suppl 1993; 38: 1–124.

2. Paus E, Theodorsen L, Engeland A. Prostate-specific antigen in serum from blood donors with subsequent cancer prostate diagnosis. Eur J Can­cer 1993, 29A, 1221–2.

3. Magnus K, Engeland A, Green BMR, Haldorsen T, Muirhead CR, Strand T. Residential radon exposure and lung cancer. An epidemiological study of Norwegian municipalities. Int J Cancer 1994; 58: 1–7.

4. Grøndahl AM, Gaustad G, Engeland A. Progression and association with lameness and racing performance of radiographic changes in the proximal sesamoid bones of young standardbred trotters Equine Vet J 1994; 26: 152–5.

5. Engeland A, Haldorsen T, Tretli S. [Prediction of cancer mortality based on relative survival analysis] Prediksjon av kreftdødelighet basert på relativ overlevelsesanalyse. Nor Epidemiol 1994; 4: 82–5.

6. Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prediction of cancer mortality in the Nordic countries up to the Years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic cancer registries. APMIS Supplement 1995; 49: 1–163.

7. Grøndahl AM, Engeland A. Influence of radiographically orthopedic changes on racing performance in Standardbred trotters. J Am Vet Med Ass 1995; 206: 1013-7.

8. Tretli S, Engeland A, Haldorsen T, Hakulinen T, Hörte LG, Luostarinen T, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prostate cancer–Look to Denmark? Letter. J Natl Cancer Inst 1996; 88: 128.

9. Engeland A, Haldorsen T, Andersen A, Tretli S. The impact of smoking habits on lung cancer risk: 28 years’ observation of 26,000 Norwegian men and women. Cancer Causes Control 1996; 7: 366–76.

10. Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years’ follow-up of 26,000 Norwegian men and women. Cancer Causes Control 1996; 7: 497–506.

11. Andersen A, Berge SR, Engeland A, Norseth T. Exposure to nickel com­pounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery work­ers. Occup Env Med. 1996; 53: 708–13.

12. Engeland A. Trends in the incidence of smoking-associated cancers in Norway, 1954–93. Int J Cancer 1996; 68: 39–46.

13. Engeland A, Bjørge T, Haldorsen T, Tretli S. Use of multiple primary cancers to indicate associations between smoking and cancer incidence. An analysis of 500,000 cancer cases diagnosed in Norway during 1953–93. Int J Cancer 1997; 70: 401-7.

14. Hafstad A, Aarø LE, Engeland A, Andersen A, Langmark F, Stray-Pedersen B. Provocative appeals in anti-smoking mass media campaigns targeting adolescent - the accumulated effect of multiple exposures. Health Education Research 1997; 12: 227-36.

15. Bjørge T, Engeland A, Hansen S, Tropé C. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954–93. Int J Cancer 1997; 71: 780-6.

16. Bjørge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S. A prospective, seroepidemiological study of the role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315: 346-9.

17. Bjørge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J. Prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997; 57: 3989-92.

18. Daae LNW, Engeland A, Freng A. [Experiences from serum protein investigations in patients with recently discovered malignant tumors in the upper digestive tract] Serumproteiner hos pasienter med nyoppdaget kreft i munn­hule/svelg. Hvilken lærdom gav konsentrasjonsmåling og elektroforese? Tidsskr Nor Laegeforen 1997; 117: 3671-3.

19. Engeland A, Bjørge T, Haldorsen T, Tretli S. Prognosis of patients with lung cancer diagnosed in Norway, 1954-1993. Cancer Causes Control 1998; 9: 57-65.

20. Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Möller TR, Storm HH, Tulinius H. Relative survival of cancer patients. A comparison between Denmark and the other Nordic countries. Acta Oncol 1998; 37: 49-59.

21. Bjørge T, Engeland A, Hansen S, Tropé CG. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer 1998; 75: 663-70.

22. Freng A, Daae LNW, Engeland A, Norum KR, Sander J, Solvoll K, Tretli S. Malignant epithelial tumours in the upper digestive tract: a dietary and socio-medical case-control and survival study. Eur J Clin Nutr 1998; 52: 271-8.

23. Engeland A, Bjørge T. [Passive smoking and risk of cancer] Passiv røyking og kreftrisiko. Tidsskr Nor Laegeforen 1998; 118: 2183-6.

24. Bjørge T, Engeland A, Hansen S, Tropé CG. [Ovarian cancer and borderline tumours.] Ovarialcancer og borderlinetumorer. Tidsskr Nor Laegeforen 1998; 118: 2471-5.

25. Grimsrud TK, Langseth H, Engeland A, Andersen A. Lung and bladder cancer in a Norwegian municipality with iron and steel producing industry: population based case-control studies. Occup Env Med 1998; 55: 387-92.

26. Bjørge T, Engeland A, Sundfør K, Tropé CG. Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. Acta Obstet Gynecol Scand 1998; 77: 777-81.

27. Storm HH, Dickman PW, Engeland A, Haldorsen T, Hakulinen T. Do morphology and stage explain the inferior lung cancer survival in Denmark? Eur Respir J. 1999; 13: 430-5.

28. Engeland A, Kopjar B. [Injuries among children] Skader blant barn behandlet ved legevakt og i sykehus 1990-97. Tidsskr Nor Laegeforen 1999; 119: 784-7.

29. Berg JP, Engeland A, Jellum E, Glattre E. Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: a matched case-control study. Thyroid 1999; 9: 285-8.

30. Bjørge T, Tropé CG, Engeland A. [Screening for cancer] Screening mot kreft. Tidsskr Nor Laegeforen 1999; 119: 1129-36.

31. Andersen A, Barlow L, Engeland A, Kjærheim K, Lynge E, Pukkala E. Work-related cancer in the Nordic countries. Scand J Work Environ Health 1999; 25 suppl 2: 1-116.

32. Engeland A, Kopjar B. [Injuries from violence in Norway - analysis of the data from the Norwegian National Injury Sample Registry] Voldsskader i Norge - en analyse av data fra personskaderegisteret. Tidsskr Nor Laegeforen 2000; 120: 714-7.

33. Kopjar B, Engeland A, Bjørndal A. Impact of the Safe Community program in Harstad on the incidence of injuries. Injury Control Saf Promotion 2000; 7: 29-39.

34. Myklestad I, Engeland A. [Product-related home injuries among pre-school children] Hjemmeulykker blant småbarn og potensiale for forebygging. Tidsskr Nor Laegeforen 2000; 120: 3376-9.

35. Sjølingstad A, Alvær K, Engeland A, Forsén L. [Registration of external causes of injuruy by ICD-10 in Norwegian hospitals] Skaderegistrering ved hjelp av ICD-10 ved norske sykehus. Tidsskr Nor Laegeforen 2001; 121: 1052-4.

36. Engeland A, Wiik J, Lande G. [Registration of parasuicide at hospitals and emergency wards] Registrering av parasuicid ved sykehus og legevakt. Tidsskr Nor Laegeforen 2001; 121: 1033-7.

37. Glattre E, Engeland A, Jellum E, Høstmark AT. Serum-albumin and risk of thyroid cancer: A population-based, matched case-control study. Nor Epidemiol 2001; 11: 197-200.

38. Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SØ, Dillner J. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87: 61-4. Erratum in Br J Cancer 2004; 91: 1226.

39. Bjørge T, Engeland A. [P-pills and risk of cancer] Bruk av p-piller og risiko for kreft. Tidsskr Nor Laegeforen 2002; 122: 1788-90.

40. Engeland A, Røysamb E, Smedslund G, Søgaard AJ. Effects of first-aid training in junior high schools. Injury Control Saf Promotion 2002; 9: 99-106.

41. Engeland A, Bjørge T, Søgaard AJ, Tverdal A. Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol 2003; 157: 517-23.

42. Engeland A, Bjørge T, Selmer RM, Tverdal A. Height and body mass index in relation to total mortality. Epidemiology 2003; 14: 293-9.

43. Engeland A, Tretli S, Bjørge T. Height, body mass index, and ovarian cancer: A follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 2003: 95: 1244-8.

44. Engeland A, Søgaard AJ. [CONOR (COhort NORway) - an overview of a unique research material] CONOR (COhort NORway) - en oversikt over en unik forskningsdatabank. Nor Epidemiol 2003; 13: 73-7.

45. Engeland A, Tretli S, Bjørge T. Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men. Br J Cancer 2003; 89: 1237-42.

46. Engeland A, Bjørge T, Tverdal A, Søgaard AJ. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 2004; 15: 79-85.

47. Engeland A, Bjørge T, Tretli S. Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women. Cancer Causes Control 2004; 15: 837-43.

48. Nystad W, Meyer HE, Nafstad P, Tverdal A, Engeland A. Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol 2004; 160: 969-76.

49. Bjørge T, Tretli S, Engeland A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 2004; 160: 1168-76.

50. Engeland A, Tretli S, Austad G, Bjørge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control 2005; 16: 987-96.

51. Bjørge T, Tretli S, Engeland A. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. Br J Cancer 2005; 93: 807-10.

52. Flugsrud GB, Nordsletten L, Espehaug B, Havelin LI, Engeland A, Meyer HE. The impact of BMI on later total hip arthroplasty due to primary osteoarthritis. A cohort study in 1.2 million persons. Arthritis Rheum 2006; 54: 802-7.

53. Bramness JG, Skurtveit S, Furu K, Engeland A, Sakshaug S, Rønning M. Endringer i salg og bruk av flunitrazepam i perioden 1999-2004. [Changes in the sale and use of flunitrazepam in Norway, 1999 - 2004.] Tidsskr Nor Laegeforen 2006; 126: 589-90.

54. Strøm H, Engeland A, Eriksen E, Rønning M. [How many and who are receiving medication for treatment of diabetes mellitus in Norway?] Hvor mange og hvem (alder og kjønn) behandles medikamentelt for diabetes mellitus i Norge? Tidsskr Nor Laegeforen 2006; 126: 768–70.

55. Bjørge T, Tretli S, Lie AK, Engeland A. The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. Cancer Causes Control 2006; 17: 983-7.

56. Engeland A , Tretli S, Akslen LA, Bjørge T. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer 2006; 95: 366-70.

57. Bjørge T, Engeland A, Tretli S, Weiderpass E. Body mass size in relation to cancer of the uterine corpus in one million Norwegian women. Int J Cancer 2007; 120, 378–83.

58. Engeland A, Tretli S, Hansen S, Bjørge T. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 2007; 165: 44-52.

59. Bramness JG, Furu K, Engeland A, Skurtveit S. Carisoprodol use and abuse – a pharmacoepidemiological study. Br J Clin Pharmaco 2007; 64: 210-8.

60. Blix HS, Engeland A, Litleskare I, Rønning M. Age and gender -specific antibacterial prescribing in Norway. J Antimicr Chem 2007; 59:971-6.

61. Bramness JG, Skurtveit S, Mørland J, Engeland A. The risk of traffic accidents after prescriptions of carisoprodol. Accid Anal Prev 2007; 39:1050-55.

62. Engeland A, Skurtveit S, Mørland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol. 2007, 17: 597-602.

63. Anderssen SA, Engeland A, Søgaard AJ, Nystad W, Graff-Iversen S, Holme I. Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. Scand J Med Sci Sports 2008; 18: 309-17.

64. Bramness JG, Engeland A, Furu K. Antidepressiver hos barn og ungdom – førte advarsler til færre forskrivninger? [Use of antidepressants among children and adolescents - did the warnings lead to fewer prescriptions?] Tidsskr Nor Laegeforen 2007; 127: 2653–5.

65. Næss Ø, Søgaard AJ, Arnesen E, Beckstrøm AC, Bjertness E, Engeland A, Hjort PF, Holmen J, Magnus P, Njølstad I, Tell GS, Vatten L, Vollset SE, Aamodt G. Cohort Profile: Cohort of Norway (CONOR). Int J Epidemiol 2008; 37: 481-5.

66. Hartz I, Sakshaug S, Furu K, Engeland A, Eggen AE, Njølstad I, Skurtveit S. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study. BMC Clin Pharmacol 2007; 7: 14.

67. Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel CI, Mørland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008; 9: 818-22.

68. Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-06. Br J Clin Pharmaco 2008; 69: 653-60.

69. Bjørge T, Cnattingius S, Lie RT, Tretli S, Engeland A. Cancer risk in children with birth defects and in their families. A population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev 2008: 17: 500-6.

70. Bjørge T, Engeland A, Tverdal A, Davey Smith G. Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230,000 Norwegian adolescents. Am J Epidemiol 2008; 168: 30-7.

71. Engeland A, Bramness JG, Mørland J, Skurtveit S. Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie. [Traffic accident risks associated with the prescription of medicinal drugs: a registry-based cohort study.] Nor Epidemiol 2008; 18: 159-65. http://www.ub.ntnu.no/journals/norepid/2008-2.html.

72. Bachs LC, Bramness JG, Engeland A, Skurtveit S. Repeated dispensing of codeine is associated with high consumption of benzodiazepines. Nor Epidemiol 2008; 18; 185-90. http://www.ub.ntnu.no/journals/norepid/2008-2.html.

73. Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A. Minor increase in risk of road traffic accidents after prescriptions of antidepressants: A study of population registry data in Norway. J Clin Psychiat 2008; 69: 1099-103.

74. Bjørge T, Engeland A, Tretli S, Heuch I. Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study. Br J Cancer 2008; 99: 1165-9.

75. Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness JG. Starting insomnia treatment: The use of benzodiazepines versus z-hypnotics.A prescription database study of predictors. Eur J Clin Pharmacol 2009; 65: 295-301.

76. Bramness JG, Grøholt B, Engeland A, Furu K. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study. J Affect Disord. 2009; 117: 208-11.

77. Bachs L, Engeland A, Mørland J, Skurtveit S. The Risk of Motor Vehicle Accidents Involving Drivers With Prescriptions for Codeine or Tramadol. Clin Pharmacol Ther 2009; 85: 596-9.

78. Skurtveit S, Strøm H, Skrivarhaug T, Mørland J, Bramness JG, Engeland A. Road traffic accident risk in patients with diabetes mellitus, receiving blood glucose-lowering drugs. Prospective follow-up study. Diabetic Med 2009; 26: 404-8.

79. Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A. An increased risk of road traffic accidents after prescriptions of lithium or valproate? Pharmacoepidemiol Drug Saf 2009; 18: 492-6.

80. Bjørge T, Cnattingius S, Engeland A, Tretli S, Lie RT, Lukanova A. Fetal Down syndrome and the risk of maternal breast cancer. Epidemiology 2009; 20: 584-89.

81. Viktil KK, Engeland A, Furu K. Use of antirheumatic drugs in mothers and fathers before and during pregnancy – a population based cohort study. Pharmacoepidemiol Drug Saf 2009: 18: 737-42.

82. Engeland A, Bjørge T, Daltveit AK, Vollset SE, Furu K. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2009; 88: 1083-9.

83. Stocks T, Borena W, Strohmaier S, Bjørge T, Manjer J, Engeland A, Johansen D, Selmer R, Hallmans G, Rapp K, Concin H, Jonsson H, Ulmer H, Stattin P. Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). Int J Epidemiol 2010; 39: 660-7.

84. Bjørge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010; 171: 892-902.

85. Bramness JG, Sandvik P, Engeland A, Skurtveit S. Does pregabalin (Lyrica^®) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database. Basic Clin Pharmacol 2010

86. Andersen JB, Engeland A, Owe JF, Gilhus NE. Myasthenia gravis requiring drug treatment in a national population cohort. Eur J Neurol 2010; 17: 1445-50.

87. Häggström C, Stocks T, Rapp K, Bjørge T, Lindkvist B, Concin H, Engeland A, Manjer J, Ulmer H, Selmer R, Tretli S, Hallmans G, Jonsson H, Stattin P. Metabolic syndrome and risk of Bladder cancer. Prospective cohort study in Metabolic syndrome and Cancer project (Me-Can). Int J Cancer 2010.

88. Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Häggström C, Stattin P, Engeland A. Metabolic syndrome and breast cancer in the Me-Can (Metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010; 19:1737-45.

89. Johansen D, Stocks T, Jonsson H, Lindkvist B, Bjørge T, Concin H, Almquist M, Häggström C, Engeland A, Ulmer H, Hallmans G, Selmer R, Nagel G, Tretli S, Stattin P, Manjer J. Metabolic Factors and the Risk of Pancreatic cancer: A Prospective analysis of almost 600,000 men and women in the Me-Can project. Cancer Epidemiol Biomarkers Prev 2010; 19: 2307-17.

90. Stocks T, Lukanova A,Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel, Tretli S, Veierød MB, Jonsson H, Stattin P. Metabolic factors and risk of colorectal cancer in 580,000 men and women in the Metabolic syndrome and Cancer project (Me-Can): a pooled cohort study. Cancer 2011; 117: 2398-407.

91. Nagel G, Concin H, Bjørge T, Rapp K, Manjer J, Hallmans G, Diem G , Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stocks T, Tretli S, Ulmer, Stattin P, Lukanova A. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). Ann Oncol 2011; 22: 1339-45.

92. Borena W, Stocks T, Jonsson H, Strohmaier S, Nagel G, Bjørge T, Manjer J, Hallmans G, Selmer R, Almquist M, Häggstöm C, Engeland A, Tretli S, Concin H, Strasak A, Stattin P,Ulmer H^. Serum triglycerides and cancer risk in the Me-Can Collaborative Study. Cancer Causes Control 2011; 22: 291-9.

93. Espnes MG, Bjørge T, Engeland A. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 2011; 20: 243-8.

94. Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. Eur J Epidemiol 2011; 26: 157-63.

95. Almquist M, Johansen D, Bjørge T, Ulmer H, Lindkvist B, Stocks T, Hallmans G, Engeland A, Rapp K, Jonsson H, Selmer R, Diem G, Häggström C, Tretli S, Stattin P, Manjer J. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can): a prospective analysis of 580,000 men and women. Cancer Causes Control 2011; 22: 743-51.

96. Handal M, Engeland A, Rønning M, Skurtveit S, Furu K. Use of prescribed opioid analgesic in women before, during and after pregnancy. A population based cohort study. Eur J Clin Pharmacol 2011; 67: 953-60.

97. Bjørge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Jonsson H, Häggström C, Stattin P, Engeland A. Metabolic risk factors and ovarian cancer in the Metabolic syndrome and cancer project. Int J Epidemiol 2011; 40:1667-77.

98. Halvorsen KH, Granås AG, Engeland A, Ruths S. Prescribing quality for older people in Norwegian nursing homes and home care services using multi-dose dispensed drugs. Pharmacoepidemiol Drug Saf 2012; 21: 929-36.

99. Borena W, Strohmaier S, Lukanova A, Bjørge T, Lindkvist B, Edlinger M, Stocks T, Nagel G, Manjer J, Engeland A, Selmer R, Häggström C, Tretli S, Concin H, Jonsson H, Stattin P, Ulmer H. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer 2012; 131: 193-200.

100. Bramness JG, Skurtveit S, Mørland J, Engeland A. An increased risk of road traffic accidents after prescriptions of methadone. Addiction 2012; 107: 967-72.

101. Edlinger M, Strohmaier S, Jonsson H, Bjørge T, Manjer J, Borena W, Häggström C, Engeland A, Tretli S, Concin H, Nagel G, Selmer R, Johansen D, Stocks T, Hallmans G, Stattin P, Ulmer H. Blood pressure and other metabolic syndrome factors and risk of brain tumor in the large population-based Me-Can cohort study. J Hypertension 2012; 30: 290-6.

102. Kieler H, Artama M, Engeland A, Ericsson Ö, Furu K, Gissler M, Nørgaard M, Nielsen RB, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B. Selective Serotonin-Reuptake Inhibitors and Risks of Persistent Fetal Circulation and Pulmonary Hypertension in the newborn. BMJ 2012.

103. Bramness JG, Furu K, Skurtveit S, Engeland A. Effect of the Market Withdrawal of Carisoprodol on Use of Other Prescribed Drugs With Abuse Potential. Clin Pharmacol 2012; 91: 438-41.

104. Ulmer H, Bjørge T, Concin H, Lukanova A, Manjer J, Hallmans G, Borena W, Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stattin P , Tretli S, Diem G, Kleiner A , Stocks T, Nagel G.Metabolic syndrome and cervical cancer in the Metabolic Syndrome and Cancer Project (Me-Can). Gyn Oncol 2012; 125: 330-5.

105. Stocks T, Van Hemelrijck M, Manjer J, Bjørge T, Ulmer H, Hallmans G, Lindkvist B, Selmer R, Nagel G, Tretli S, Concin H, Engeland A, Jonsson H, Stattin P. Blood Pressure and Risk of Incident and Mortality in the Metabolic Syndrome and Cancer Project. Hypertension 2012; 59: 802-10.

106. Viktil KK, Engeland A, Furu K. Outcomes after antirheumatic drug use before and during pregnancy - a cohort study among 150 000 mothers and expectant fathers. Scand J Rheumatol 2012; 41:196-201.

107. Nagel G, Bjørge T, Stocks T, Manjer J, Hallmans G, Edlinger M, Häggström C, Engeland A, Johansen D, Kleiner A, Selmer R, Ulmer H, Tretli S, Jonsson H, Concin H, Stattin P, Lukanova A. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). Br J Dermatol 2012; 167: 59-67..

108. Nagel G, Ulmer H, Späth D, Hjartåker A, Lindkvist B, Hallmans G, Diem G, Jonsson H, Bjørge T, Manier J, Häggström C, Engeland A, Stocks T, Selmer R, Concin H, Stattin P, Schlenk RF. Metabolic syndrome and blood cancers in the Me-Can (Metabolic syndrome and Cancer) project. Ann Hematol 2012; 10: 1519-31.

109. Bakken MS, Ranhoff AH, Engeland A, Ruths S. Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards. Scand J Prim Health Care 2012; 30: 169-75.

110. Häggström C, Stocks T, Ulmert D, Bjørge T, Ulmer H, Hallmans G, Manjer J, Engeland A, Nagel G, Almqvist M, Selmer R, Concin H, Tretli S, Jonsson H, Stattin P. Metabolic factors and risk of prostate cancer. Cancer 2012; 118: 6199-206.

111. Svendal G, Fasmer OB, Engeland A, Berk M, Lund A. Coprescription of medication for bipolar disorder and diabetes mellitus: A nationwide population-based study. BMC Med 2012; 10:148.

112. Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K. Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340,000 pregnancies using Norwegian population-based databases. Br J Clin Pharmacol 2013; 75: 1134-41.

113. Lund IO, Handal M, Engeland A, Furu K, Ravndal E, Skurtveit S. Prescription drug use among mothers in Opioid maintenance treatment. Addiction 2013; 108: 367-76.

114. Lindkvist B, Almqvist M, Johansen D, Bjørge T, Stocks T, Ulmer H, Hallmans G, Engeland A, Nagel G, Jonsson H , Selmer R, Diem G, Häggström C, Tretli S, Stattin P, Manjer J. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control 2013; 24: 107-16.

115. Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, Gissler M, Nörgaard M, Nielsen RB, Zoega H, Valdimarsdottir U. Selective Serotonin Reuptake Inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 2013; 309: 48-54.

116. Håberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO, Skrondal A, Cappelen I, Engeland A, Aavitsland P, Madsen S, Buajordet I, Furu K, Nafstad P, Vollset SE, Feiring B, Nøkleby H, Wilcox AJ, Magnus P, Stoltenberg C. Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination. N Engl J Med 2013: 368: 333-40.

117. Strohmaier S, Edlinger M, Stocks T, Bjørge T, Manjer J, Borena W, Häggström C, Engeland A, Nagel G, Almquist M, Selmer R, Tretli S, Concin H, Hallmans G, Jonsson H, Stattin P, Ulmer H. Total Serum Cholesterol and Cancer Incidence in the Metabolic syndrome and Cancer (Me-Can) project. PLOS ONE 2013; 8.

118. Bakken MS, Engeland A, Engesæter LB, Ranhoff AH, Hunskår S, Ruths S. Increased hip fracture risk in older persons using antidepressant drugs: Data from the Norwegian Prescription Database and the Norwegian Hip fracture Register. Age ageing 2013: 42: 514-20.

119. Häggström C, Rapp K, Stocks T, Manjer J, Bjørge T, Ulmer H, Engeland A, Almqvist M, Concin H, Selmer R, Ljungberg B, Tretli S, Nagel G, Hallmans G, Jonsson H, Stattin P. Metabolic factors associated with risk of renal cell carcinoma. PLOS ONE 2013.

120. Ghaderi S, Engeland A, Moster D, Ruud E, Syse A, Wesenberg F, Bjørge T. Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: A Norwegian population-based cohort study. Br J Cancer 2013; 108: 1525-33.

121. Bjerkaas E, Parajuli R, Weiderpass E, Engeland A, Mascarinec G, Selmer R, Gram IT. Smoking duration before first childbirth: An emerging risk factor for breast cancer? Results from 302 865 Norwegian women. Cancer Causes Control 2013; 24: 1347-56.

122. Bjørge T, Sørensen HT, Grotmol T, Engeland A, Stephansson O, Gissler M, Tretli S, Troisi R. Fetal growth and childhood cancer: A population-based study. Pediatrics 2013; 132: e1265-75.

123. Wirén S, Häggström C, Ulmer H, Manjer J, Bjørge T, Nagel G, Johansen D, Hallmans G, Engeland A, Concin H, Jonsson H, Selmer R, Tretli S, Stocks T, Stattin P. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 2014; 25: 151-9.

124. Borena W, Edlinger M, Bjørge T, Häggström C, Lindkvist B, Nagel G, Engeland A, Stocks T, Strohmaier S, Manjer J, Selmer R, Tretli S, Concin H, Hallsman G, Jonsson H, Stattin P, Ulmer H. A prospective study on the association between metabolic risk factors and gallbladder cancer incidence in the Me-Can Syndrome and Cancer (Me-Can collaborative study. PLOS One 2014.

125. Andersen JB, Heldal AT, Engeland A, Gilhus NE. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurol Scand Suppl. 2014; 198: 26-31.

126. Andersen JB, Heldal AT, Engeland A, Gilhus NE. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurol Scand Suppl. 2014; 198: 26-31.

127. Andersen JB, Engeland A, Owe JF, Gilhus NE. Total drug treatment and comorbidity in myasthenia gravis; a population-based cohort study. Eur J Neurol 2014; 21: 948-55.

128. Løkeland M, Iversen OE, Engeland A , Økland I, Bjørge L. Medical abortion with mifepristone and home administration of misoprostol up to 63 days gestation. AOGS 2014; 93: 647-53.

129. Bakken MS, Engeland A, Engesæter LB, Ranhoff AH, Hunskår S, Ruths S. Risk of Hip Fracture among Older People Using Anxiolytic and Hypnotics: A nationwide registry-based study. Eur J Clin Pharmacol 2014; 70: 873-80.

130. Bjerkaas E, Parajuli R, Weiderpass E, Engeland A, Mascarinec G, Gram IT. The association between lifetime smoking exposure and breast cancer mortality- Results from a Norwegian cohort. Cancer Med 2014; 3: 1448-57.

131. Häggström C, Stocks T, Nagel G, Manjer J, Bjørge T, Hallmans G, Engeland A, Ulmer H, Lindkvist B, Selmer R, Concin H, Tretli S, Jonsson H, Stattin P. Risk of prostate cancer, prostate cancer death, and death from other causes for men with metabolic aberrations. Epidemiology 2014; 25: 823-8.

132. Riska BS, Engeland A, Skurtveit S, Furu K, Handal M. Use of prescribed benzodiazepines and benzodiazepine related drugs in pregnant women: a population-based cohort study. Eur J Clin Pharmacol 2014; 11: 1367-74.

133. Kieler H, Malm H, Artama M, Engeland A, Furu K, Gissler M, Nørgaard M, Nielsen RB, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B. Use of antidepressants and termination of pregnancy: population based case-control study from three Nordic countries. BJOG 2014.

134. Stocks T, Bjørge T, Ulmer H, Manjer J, Häggström C, Nagel G, Engeland A, Johansen D, Hallmans G, Selmer R, Concin H, Tretli S, Jonsson H, Statin P. Metabolic syndrome score and cancer incidence and mortality: a pooled analysis of seven cohorts.Int J Epidemiol 2015.

135. Bjerkaas E, Parajuli R, Engeland A, Mascarinec G, Weiderpass E, Gram IT. Social inequalities and smoking-associated breast cancer – results from a prospective cohort study. Prev Med 2015

136. Engeland A, Bjørge T, Klungsøyr K, Skjærven R, Skurtveit S, Furu K. Preeclampsia in pregnancy and later use of antihypertensive drugs. Eur J Epidemiol 2015; 30: 501-8.

137. Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, Valdimarsdottir U, Zoega H, Artama M, Gissler M, Malm H, Nørgaard M. Selective Serotonin-Reuptake Inhibitors and Venlafaxine in early pregnancy and risk of birth defects – a population based cohort study and sibling design. BMJ 2015.

138. Ghaderi S, Engeland A, Gunnes MW, Moster D, Ruud E, Syse A, Wesenberg F, Bjørge T. Educational attainment and choice of educational field among long-term survivors of cancer in childhood and adolescence: A Norwegian population-based cohort study. Journal of Cancer Survivorship (JCSU) 2015.

139. Charlton RA, Garne E, Wang H, Klungsøyr K, Jordan S, Neville AJ, Pierini A, Hansen AV, Engeland A, Gini R, Thayer D, Tingay K, Bos HJ, Puccini A, Nybo-Andersen AM, Dolk H, de Jong-van den Berg LTW, de Vries CS. Antiepileptic drug prescribing before, during and after pregnancy: a study in 7 European regions. Pharmacoepidemiol Drug Saf 2015; 24: 1144-54.

140. Ruths S, Bakken MS, Ranhoff AH, Hunskår S, Engesæter LB, Engeland A. Risk of hip fracture among older people using antihypertensive drugs: A nationwide  cohort study. BMC Geriatr 2015.

141. Instanes JT, Holmøy A, Engeland A, Haavik J, Furu K, Klungsøyr K. Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and Immune system diseases. Biological Psychiatry 2015.

142. Charlton RA, Pierini A, Klungsøyr K, Neville A, Jordan S, de Jong-van den Berg LTW, Thayer D, Bos HJ, Puccini A, Hansen AV, Gini R, Engeland A, Andersen AMN, Dolk H, Garne E. Asthma medication prescribing before, during and after pregnancy: a study in seven European regions. BMJ Open 2016.

143. Garne E, Vinkel Hansen A, Morris J, Jordan S, Klungsøyr K, Engeland A, Tucker D, Thayer DS, Davies GI, Nybo-Andersen AM, Dolk H^. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study. BJOG 2016.

144. Charlton RA, Klungsøyr K, Neville AJ, Jordan S, Pierini A, de Jong-van den Berg LTW, Bos HJ, Puccini A, Engeland A, Gini R, Davies G, Thayer D, Hansen A, Wang H, McGrogan A, Nybo Andersen AM, Dolk H, Garne E. Prescribing of antidiabetic medicines before, during and after pregnancy: a study in seven European regions.Plos One 2016.

145. Bakken MS, Schjøtt J, Engeland A, Engesæter LB, Ruths S. Antipsychotic drugs and risk of hip fracture in people aged 60 and older in Norway. J Am Geriatr Soc 2016.

146. Knudsen-Baas KM, Engeland A, Gilhus NE Storstein AM, Owe JF. Does the choice of antiepileptic drug affect survival in glioblastoma patients? J NeuroOncology 2016.

147. Bjørge T, Gissler M, Ording A, Engeland A, Glimelius I, Leinonen M, Sørensen HT, Tretli S, Ekbom A, Troisi R, Grotmol T. Reproductive history and risk of colorectal adenocarcinoma in parous women: A Nordic population-based case-control study. Br J Cancer 2016.

148. Magnus MC, Håberg SE, Magnus P, Engeland A, Karlstad Ø, Nafstad P, Nystad W. Pre-eclampsia and childhood asthma. Eur Resp J 2016.

149. Jordan S, Morris J, Davies GI, Tucker D, Thayer DS, Luteijn JM, Morgan M, Garne E, Hansen AV, Klungsøyr K, Engeland A, Boyle B, Dolk H. Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in Pregnancy and Congenital Anomalies: analysis of linked databases in Wales, Norway and Funen, Denmark. Plos One 2016.

150. Hjerkind KV, Gislefoss R, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth H. Cohort Profile Update: The Janus Serum Bank Cohort in Norway. Int J Epidemiol 2017.

151. Engeland A, Bjørge T, Klungsøyr K, Skurtveit S, Furu K. Preterm births and use of medication in early adulthood: A population-based registry study. Pharmacoepidemil Drug Saf 2017.

152. Graner S, Svensson T, Beau A, Damase-Michel C, Engeland A, Håberg SE, Furu K, Hviid AP, Mølgaard- Nielsen D, Pasternak B, Kieler H. Neuraminidase inhibitors during pregnancy, and the risk of adverse neonatal outcomes and congenital malformations- A population based European register study. BMJ 2017.

153. Mittal S, Bjørnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Park DS, Schule B, Riise T, Scherzer

154. Hegvik TA, Instanes JT, Haavik J, Klungsøyr K, Engeland A. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. Eur J Child Adol Psych 2017

155. Charlton RA, Bettoli V, Bos HJ, Engeland A, Garne E, Gini R, Hansen AV, de Jong-van den berg LTW, Jordan S, Klungsøyr K, Neville AJ, Pierini A, Puccini A, Sinclair M, Thayer D, Dolk H, The limitations of some European healthcare databases for monitoring the effectiveness of Pregnancy Prevention Programmes as risk minimisation measures. Eur J Clin Pharm 2017.      

156. Huybrechts KF, Bröms G, Christensen B, Einarsdóttir K, Engeland A, Furu K,  Gissler M, Hernandez-Diaz S, Karlsson P, Karlstad Ø, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Sørensen HT, Zoega H, Bateman BT. Stimulant Use in Pregnancy and Risk of Congenital Malformations: A cohort study from the International Pregnancy Safety Study (InPreSS) Consortium. JAMA Psych 2017.

157. Antonazzo IC, Riise T, Cortese M, Berge LI, Engeland A, Fasmer OB, Lund A, Ødegaard KJ, Poluzzi E, Bjørnevik K. Diabetes is associated with decreased migraine risk: a nationwide cohort study. Cephalalgia 2018: 38: 1759-64.

158. Solberg BS, Halmøy A, Engeland A, Igland J, Haavik J, Klungsøyr K. Gender differences in Psychiatric Comorbidity in Adults with Attention Deficit/Hyperactivity Disorder. Acta Psychiatr Scand 2018; 137: 176–186.

159. Nechanská B, Moravcik V, Skurtveit S, Lund IO, Gabrhelik R, Engeland A, Handal M. Neonatal Outcomes after Fetal Exposure to Methadone and Buprenorphine: National Registry Studies from the Czech Republic and Norway. Addiction 2018.

160. Cortese M, Riise T, Engeland A, Ascherio A, Bjørnevik K. Urate and the risk of Parkinson’s disease in men and women. Parkinsonism Relat Disord 2018.

161. Sköld C, Bjørge T, Ekbom A, Engeland A, Gissler M, Grotmol T, Madanat L, Ording A, Stephansson O, Trabert B, Tretli S, Troisi R, Sørensen HT, Glimelius I. Pregnancy-related risk factors for epithelial ovarian cancer in parous women. Int J Cancer 2018.

162. Troisi R, Sørensen HT, Grotmol T, Glimelius I, Engeland A, Gissler M, Trabert B, Ekbom A, Gulbech Ording A,Tretli S, Bjørge T. Pregnancy Complications and Subsequent Breast Cancer Risk in the Mother: A Nordic population-based case-control study. Int J Cancer 2018.

163. Pasternak B, Wintzell V, Furu K, Engeland A, Neovius M, Stephansson O. Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death. JAMA 2018.

164. Engeland A, Bjørge T, Klungsøyr K, Hjellvik V, Skurtveit S, Furu K. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005-2015. Pharmacoepidemiol Drug Saf 2018.

165. Bateman BT, Heide-Jørgensen U, Einarsdottir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Huybrechts K, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Nørgaard M, Reutfors J, Selmer R, Zoega H. Beta-blocker use in pregnancy and the risk of congenital malformations: An international cohort study. Ann Intern Med 2018; 169: 665-73.

166. Häggström C, Jonsson H, Bjørge T, Nagel G, Manjer J, Ulmer H, Drake I, Ghaderi S, Lang A, Engeland A, Stattin P, Stocks T. Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals. Int J Cancer 2019.

167. Fritz J, Bjørge T, Nagel G, Manjer J, Engeland A, Häggström C, Concin H, Teneka S, Tretli S, Gylling B, Lang A, Stattin P, Stocks T, Ulmer H. The Triglyceride-Glucose index and risk of obesity-related cancers: a mediation analysis. Int J Epidemiol 2019.

168. Solberg BS, Zenyats T, Posserud MB, Halmøy A, Engeland A, Haavik J, Klungsøyr K. Psychiatric comorbidity and genetic correlations provide new insights into differences between attention-deficit/hyperactivity disorder and autism spectrum disorder. Biological Psychiatry 2019.

169.  Trabert B, Troisi R, Grotmol T, Ekbom A, Engeland A, Gissler M, Glimelius I, Madanat-Harjuoja L, Sørensen HT, Tretli S, Ording AG, Bjørge T. Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: a Nordic population-based case-control study. Int J Cancer 2019.

170. Handal M, Nechanská B, Skurtveit S, Lund IO, Gabrhelik R, Engeland A, Moravcik V. Prenatal exposure to Opioid Maintenance Treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway. Pharmacol Res Perspect. 2019;e00501. https ://doi.org/10.1002/prp2.501.

171. Bjørge T, Häggström C, Ghaderi S, Lang A, Nagel G, Manjer J, Tretli S, Ulmer H, Harlid C, Rosendahl A, Lang A, Stattin P, Stocks T, Engeland A. BMI/weight changes and cancer risk in the Metabolic Syndrome and Cancer Study (MeCan 2.0): A pooled analysis of six European cohorts. Int J Epidemiol 2019.

172. Børsheim AW, Engeland A, Gilhus NE. Epilepsy and autoimmune diseases: comorbidity in a national patient cohort. Seizure 2020; 75: 89-95.

173. Reutfors J, Cesta CE, Cohen JM, Bateman BT, Brauer R, Einarsdóttir K, Engeland A, Furu K, Gissler M, Havard A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Leinonen MK, Li J, Man K, Pazzagli L, Schaffer A, Schink T, Wang Z, Yu Y, Zoega H, Bröms G. Antipsychotic Drug Use in Pregnancy: A multinational study from ten Countries. Schizophrenia Research 2020.

174. Sköld C, Bjørge T, Ekbom A, Engeland A, Gissler M, Grotmol T, Madanat L, Ording A, Trabert B, Tretli S, Troisi R, Sørensen HT, Glimelius I. Pregnancy-related risk factors for sex cord-stromal tumors and germ cell tumors in parous women: A registry-based study. Br J Cancer 2020.

175. Reigstad MM, Storeng R, Furu K, Bakken IJ, Engeland A, Larsen IK. Validation of Assisted Reproductive techniques in the Medical Birth Registry of Norway versus the Norwegian Prescription Database. Epidemiology 2020.

176. Cesta CE, Engeland A, Karlsson P, Kieler H, Reutfors J, Furu K.  A Incidence of malformations after early pregnancy exposure to modafinil detected in Sweden and Norway. JAMA 2020.

177. Felde G, Engeland A, Hunskaar S. Anxiety and depression associated with urinary incontinence: Cross-sectinal study from the Norwegian Prescription Database and HUNT study on the impact of psychotropic drugs. BMC Psychiatry 2020.

178. Daltveit DS, Klungsøyr K, Engeland A, Ekbom A, Gissler M, Glimelius I, Grotmol T, L, Madanat L, Ording AG, Sæther SMM, Sørensen HT, Troisi R, Bjørge T. Cancer risk in individuals with major birth defects: a large Nordic population-based case-control study among children, adolescents and adults. BMJ 2020.

179. Kitahara CM, Daltveit DS, Ekbom A, Engeland A, Gissler M, Glimelius I, Grotmol T, Lagerros YT, Madanat-Harjuoja L, Männistö T, Sørensen HT, Troisi R, Bjørge T. Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study. Lancet Diab Endocrinol 2020.

180. Solberg BS, Hegvik TA, Halmøy A, Skjærven R, Engeland A, Haavik J, Klungsøyr K. Sex differences in parent-offspring recurrence of attention-deficit/hyperactivity disorder.  J Child Psychol Psych 2020.

181. Nagel G, Bjørge T, Jaensch A, Peter RS, Häggström C, Lang A, Engeland A, Teleka S, Jirström K, Linquist D, Stattin P, Ulmer H, Concin H, Stocks T. Metabolic factors and the risk of small intestine cancers: pooled study of 800 000 individuals in the Metabolic syndrome and Cancer project. Int J Cancer 2021.

182. Engeland A, Ghaderi S, dos-Santos-Silva I, Furu K, Hjellvik V, Kvåle R, Bjørge T. Prescribed drugs in 27,000 individuals after diagnosis of colorectal cancer; a population-based cohort study. Pharmacoepidemiol Drug Saf 2021; 30:1037–48.

183. Wood AM, Jonsson H^, Nagel G, Häggström C, Manjer J, Ulmer H, Engeland A, Zitt E, Jochems S, Ghaderi S, Stattin P, Bjørge T, Stocks T. The inverse association of body mass index with lung cancer: exploring residual confounding, metabolic aberrations and within-person variability in smoking. Cancer Epidemiol Biomarkers Prev 2021.

184. Cesta CE, Chacón SS, Engeland A, Broe A, Damkier P, Furu K, Kieler H, Karlsson P. Use of Sildenafil and other Phosphodiesterase Type 5 Inhibitors among pregnant women in Scandinavia. Acta Obstetricia et Gynecologica Scandinavica 2021.

185. Posserud MB, Solberg BS, Engeland A, Haavik J, Klungsøyr K Male-female ratios in autism spectrum disorders by age and comorbid intellectual disability. A population-based study, 1967-2005. Acta Psychiatr Scand 2021.

Long-term adverse health effects in cancer patients: Prescribing of drugs in survivors of adult-onset cancer 

In this study, we take advantage of nationwide population-based registries and databases to explore long-term adverse health effects in survivors of adult-onset cancer (≥20 years). Specifically, we aim to examine the use of prescribed drugs, as proxies for specific diseases, in cancer patients compared with the general population. In sub-analyses, we will also examine prescription of drugs shortly before and after cancer diagnosis. The linked dataset includes information from the Cancer Registry of Norway and the Norwegian Prescription Database, in addition to other national registries and databases. Prescribing of drugs may provide the most comprehensive assessment of long-term health-related outcomes among cancer survivors.

Metabolic Syndrome and Cancer project (Me-Can) http://me-can.se/

In 2006, cohorts from Austria, Norway and Sweden were linked to national registries in the Me-Can 1.0 project. Data from almost 600,000 men and women were used to study various metabolic factors in relation to cancer risk. The Me-Can collaboration continues within the Me-Can 2.0 project where the aim is to characterise the metabolic syndrome-cancer relationship in more detail by adding new variables from cohort questionnaires and new register linkages, and new participants from the cohorts, by updating linkages to national cancer and cause of death registers, and by implementing new statistical methods. Several studies are ongoing.

Nordic Countries Linked Birth and Cancer Registries Cohort Project

Complex biological mechanisms promote carcinogenesis, and there is increasing evidence that pregnancy related exposures influence foetal growth cell division and organ functioning and may have a long-lasting impact on health and disease susceptibility in the mothers and offspring. Linking health registries, such as medical birth, cancer and patient registries, and pooling of data in the Nordic countries (Denmark, Finland, Norway and Sweden) have provided opportunities to conduct epidemiologic research of pregnancy exposures and subsequent cancer development. Several studies are ongoing.

Improving prognosis of patients with glioblastoma: Linking health registry and clinical data to basic brain tumour research (GlioLink)

The GlioLink project will combine basic brain tumour research with nationwide population-based health registry and clinical data in order to screen brain penetrating drugs for their anti-tumour effects where the aim is to identify novel targets and develop new treatment strategies for glioblastoma.

In this project, we will, based on information from the Cancer Registry of Norway, the Norwegian Prescription Database and other national databases, investigate whether the use of antipsychotics and antidepressants is associated with a prolonged survival among patients with glioblastoma. We will also investigate whether the use of these drugs is associated with a lower risk of developing glioblastoma. Several factors that affect the prognosis for patients with glioblastoma will be investigated in supplementary analyzes of clinical data. The drugs identified in the observational studies will be tested and further developed in the laboratory. Since it is likely that the newly developed drugs will not have an effect on all patients, we will also test the effect of the drugs in tissue samples from patients with glioblastoma.

Pregnancy conditions and birth characteristics in relation to cancer in childhood and adolescence